Generally, I try to reserve Inflection Point for breaking news, and it’s tough to justify highlighting a Wall Street Journal editorial in this slot. Bear with me. The WSJ editorial
It’s a big 340B day, starting with a decision by a federal appeals court to side with Arkansas in a dispute with PhRMA. Arkansas has a law that says that
I’m finally through uploading the transcripts from almost all** of the CMS patient-focused listening sessions around the 10 drugs slated for price controls under the Inflation Reduction Act. You can